AbbVie expects acquisition to cut 2026 adj EPS by 14c (partial year)
AbbVie expects an acquisition to negatively impact 2026 adjusted EPS by 14c for a partial year.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.